From: Antimicrobial resistance from a One Health perspective in Zambia: a systematic review
Resistance type | Number of Articles | AMR context (Samples studied) | Output | ||||
---|---|---|---|---|---|---|---|
 |  | Human (H) | Animal (A) | Environmental (E) | One Health (AHE) | Policy | Surveillance |
a | |||||||
Antibacterial | 16 | 9 (+ 2) | 2 (+ 2) | 2 (+ 2) | 3 (AE, HE, HA) | 0 | 16 |
Antimalarial | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
Antiviral | 3 | 3 | 0 | 0 | 0 | 0 | 3 |
Antitubercular | 5 | 5 | 0 | 0 | 0 | 0 | 5 |
Antifungal | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 25 | 18 (20) | 2 (4) | 2 (4) | 3 | 0 | 25 |
 | Pathology in human samples | n (%) (n = 20) | Study |
---|---|---|---|
b | |||
1 | Breast abscess | 1 (5) | Kapatamoyo et al. [16] |
2 | Cholera | 1 (5) | Mwape et al. [17] |
3 | Chronic suppurative otitis media | 1 (5) | Matundwelo and Mwansasu [18] |
4 | Diarrheal disease | 2 (10) | |
5 | HIV | 4 (20) | Gill et al. [22], Bennett et al. [23], Inzaule et al. [24], Miti et al. [25] |
6 | Hospital acquired infections | 1 (5) | Chanda et al. [26] |
7 | Malaria | 1 (5) | Bijl et al. [27] |
8 | Neonatal sepsis | 1 (5) | Kabwe et al. [28] |
9 | Not mentioned | 2 (10) | |
10 | Tuberculosis | 5 (25) | Mulenga et al. [31], Habeenzu et al. [32], Kapata et al. [33, 34], Masenga et al. [35], Kapata et al. [33, 34] |
11 | Typhoid | 1 (5) | Hendriksen et al. [36] |
 | Samples | Human studies | Animal studies | Total Studies (A + E) | Total % |
---|---|---|---|---|---|
c | |||||
1 | Blood | 7 | Â | 7 | 26 |
2 | Sputum | 5 | Â | 5 | 19 |
3 | Stool | 4 | Â | 4 | 15 |
4 | Wound Swab | 3 | 1 | 4 | 15 |
5 | Aspirates | 1 | Â | 1 | 4 |
6 | Nasal swab | 1 | 1 | 2 | 7 |
7 | Rectal swab | 1 | Â | 1 | 4 |
8 | Urine | 1 | Â | 1 | 4 |
9 | Oral swab | 1 | 1 | 2 | 7 |